[1]
2024. India’s Use of Patent Opposition Mechanism as an Access to Drugs Strategy: An Empirical Analysis. Journal of Intellectual Property Rights (JIPR). 29, 4 (Jul. 2024), 253–264. DOI:https://doi.org/10.56042/jipr.v29i4.3704.